[7/14 Webinar] The latest information on the enforcement and procurement of US patents
XNUMX.Enforcing Your U.S. Patents – Robert Maier and Jennifer Tempesta will discuss factors to consider in determining whether and how best to assert patents against your competitors and others in the market, including pros and cons that may arise in connection with such patent assertion.
XNUMX.Recent ITC Developments – The U.S. International Trade Commission had reached another record high level of Section XNUMX complaints. Lisa Kattan will address new developments in the ITC law stemming from this busy docket.
XNUMX. Development of High Quality Data-Driven Patent Portfolios – Dr. Michael Sartori will explore the use of data analytics to assist in decision making for the development of high quality patent portfolios.
◆ Title: The latest information on the enforcement and procurement of US patents
◆Date: Thursday May 2022th 7 @ 14:9 ～ 30:10 (JST)
◆ Webinar type: Zoom Webinar
Baker Botts LLP
Dr. Michael Sartori is a partner in the firm's Intellectual Property Department. As a registered patent attorney, he focuses his practice on patent prosecution, patent portfolio counseling, and patent litigation. Prior to joining Baker Botts, Dr. Sartori served for over a decade as Chair of the Patent Prosecution and Counseling Group at another AMLaw XNUMX firm.
For patent prosecution and counseling, Dr. Sartori is a recognized thought leader in using Examiner analytics and provides a comprehensive, business-goal-orientated, data-driven approach to developing and managing his client's patent portfolios. Keeping his client's business objectives in mind, Dr. Sartori crafts and implements cost-effective strategies to assist his client's goals for their patent portfolio, whether U.S. only or worldwide.
For patent litigation and counseling, Dr. Sartori provides guidance prior to and during patent litigation, whether in an inter partes review (IPR), at a U.S. district court, or at the Federal Circuit. He often serves as part of a cohesive and tactical litigation team that is driven to assist with the client's litigation goals. He has also provided opinions leading up to litigation, including infringement, validity and enforceability opinions, as well as freedom-to-operate opinions.
Baker Botts LLP
Lisa Kattan serves as Baker Botts' International Trade Commission Practice Group Chair and the Chair of the firm's Washington D.C. IP group. Prior to joining Baker Botts, she was a Senior Investigative Attorney at the U.S. International Trade Commission's Office of Unfair Import Investigations for over five years. At the ITC, Ms. Kattan's responsibilities included serving as lead trial counsel on behalf of the U.S. Government in numerous high-profile investigations of accused products. She has been counsel in dozens of ITC proceedings, both at the ITC and in private practice.
Noted as "an ace up the firm's sleeve for Section XNUMX investigations" (IAM XNUMX, XNUMX), Ms. Kattan is a recognized ITC practitioner in Chambers USA (XNUMX-XNUMX), IAM XNUMX (XNUMX-XNUMX) and as a "Leading Lawyer" in The Legal XNUMX U.S. (XNUMX-XNUMX). Ms. Kattan is a frequent speaker on ITC developments and patent litigation best practices.
Baker Botts LLP
Rob Maier is a lead trial lawyer at Baker Botts, and Chair of the Intellectual Property Group in our New York office. Multinational clients involved in patent and other IP cases across a broad spectrum of technologies, from semiconductor manufacturing and smartphones, to drink packaging and stem cells, rely on Rob's extensive experience.
Rob leads trial teams both in district courts and the ITC. His practice also extends into PTAB matters, patent preparation and prosecution, counseling on IP and big data issues, and due diligence in mergers and acquisitions. Described by clients and peers as "one of the most skilled people you are ever likely to see in the courtroom," and as a "strong, practical advocate," (IAM Patent 1000-The World's Leading Patent Practitioners, 2012-2016).
Baker Botts LLP
Jennifer Tempesta is a trial lawyer whose practice focuses on patent litigation in both district courts and the International Trade Commission. Multinational clients rely on Jennifer's significant experience with all phases of litigation in various jurisdictions, including discovery, Markman hearings, summary judgment, and through trial.
Jennifer is also well-versed in appellate practice and has argued at the Court of Appeals for the Federal Circuit. Jennifer also handles proceedings at the Patent Trial and Appeal Board. As a registered patent attorney with strong technical acumen, clients seek Jennifer's advice in a number of fields, including payment processing, smartphones, chemicals and pharmaceuticals.
Articles in the same category
[Real Seminar on June 6th] Initial Response and Legal Actions in Case of Trade Secret Leakage ~Collaboration between Departments and Digital Forensics~
[June 6nd Webinar] How Japanese Companies Gain an Advantage in US Lawsuits. -How to reduce the advantages and disadvantages unique to Japanese companies-
[6/8 Webinar] Latest US Department of Justice (DOJ) corporate crackdown policy and its impact on Japanese companies
[Webinar held on June 6] Comparative study of what companies are required to do regarding business and human rights and the actual efforts of each company -Aiming for further respect for human rights and improvement of corporate value-
[Held on May 5th!25nd Economic Security Study Group] "New Phase of M&A for Japan and China Money, Detailed Explanation with Actual Cases" The whole story of how a Chinese entrepreneur who escaped from the Xi Jinping regime set up a takeover in Japan
[Event held on May 5] "Initial response and legal measures in the event of trade secret leaks" by retirees taking out information ~Interdepartmental collaboration and digital forensics~
[May 5th Webinar] Introduction of utilization cases of disease network analysis by natural language processing AI
[May 5th Webinar] Protecting Japanese Companies from U.S. Regulators -- "Best Measures" and "Latest Trends"
[5/23 5th Fraud Countermeasures Study Group] Hypotheses and countermeasures based on the ranking of "100 companies with a large number of whistleblowing cases" Fraud risks that cannot be measured only by the number of whistleblowing reports Former editor-in-chief of Toyo Keizai "CSR Company Directory" Detailed explanation
Commonly viewed articles
Chugai Pharmaceutical Co., Ltd. has been posted as an introductory user.
FRONTEO's finance in NHK Close-up Gendai + "How to protect your assets? -Prescription for the ultra-low interest rate era-" broadcast on 10/30 ...
Comprehensive support for marriage activities using artificial intelligence KIBIT at the NHK special "Artificial Intelligence Angel or Devil 9" broadcast on 15/2018 ...
FRONTEO has been entrusted with an empirical research project utilizing artificial intelligence in the 30 JPO open call for participants project, following last year.